In particular, P2Y12 and P2Y6 receptor signaling have been specifically identified as primary drivers of altered microglial Ca2+ activity in mouse models of Alexander's disease and epileptogenesis (Saito et al. 2024; Umpierre et al. 2024). Here, P2RY6 is linked to Alexander disease.